Medicxi Growth I LP 13D and 13G filings for Centessa Pharmaceuticals plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-31 4:00 pm Purchase |
2022-12-31 | 13G | Centessa Pharmaceuticals plc CNTA |
Medicxi Growth I LP | 19,963,157 21.100% |
1,839,265 (+10.15%) |
Filing |
| 2022-02-08 08:27 am Purchase |
2021-12-31 | 13G | Centessa Pharmaceuticals plc CNTA |
Medicxi Growth I LP | 18,123,892 20.160% |
18,123,892 (New Position) |
Filing |